Skip to content

clinical evaluation of (99m)TC-HYNIC/EDDA-TMTP1 in gynecology tumor imaging

clinical evaluation of (99m)TC-HYNIC/EDDA-TMTP1 in gynecology tumor imaging

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-13003771
Enrollment
Unknown
Registered
2013-10-28
Start date
2014-01-07
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer and cervical cancer

Interventions

Gold Standard:
Index test:

Sponsors

Gynaecological Oncology and Nuclear medicine of Tongji hospital affiliated to huazhong university of science and technology
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ?Female patients with age more than 18 yeas; ?The patients have been diagnosed with cervical cancer or ovarian cancer; ?Without receving radioactive drugs for diagnosis or treatment, recently; ?It must fullfill the ethical requirements and patient have signed a informed consent.

Exclusion criteria

Exclusion criteria: ?They are Pregnancy or nursing mothers; ?Having drugs or alcohol dependence; ?Hypersensitive to the active or inactive ingredients of the study drug; ?Having attendd other drug clinical trials within three months; ?Cardiac functional insufficiency; ?Hepatic and renal function insufficiency; ?Hypertensive patients with serious complications; ?Endangering the safety of life.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Accurac;

Contacts

Public ContactDing Ma
dingma424@126.com+86 13886090620

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026